메뉴 건너뛰기




Volumn 46, Issue 9, 2011, Pages 3867-3876

Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluation

Author keywords

AT1 receptor antagonists; Copper catalyzed; Patent escaping; Pyrazoles. C to N bioisosterism; Ullmann; Ullmann Finkelstein

Indexed keywords

3 (ACETYL M TOLYL AMINO) 1 (2' CYANO BIPHENYL 4 YLMETHYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 (ACETYL M TOLYL AMINO) 1 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 (ACETYL P TOLYL AMINO) 1 (2' CYANO BIPHENYL 4 YLMETHYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 (ACETYL P TOLYL AMINO) 1 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 (ACETYL PHENYL AMINO) 1 (2' CYANO BIPHENYL 4 YLMETHYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 (ACETYL PYRIDIN 3 YL AMINO) 1 (2' CYANO BIPHENYL 4 YLMETHYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 (ACETYL PYRIDIN 3 YL AMINO) 1 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 (ACETYLPHENYL AMINO) 1 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 [ACETYL (3,5 DIMETHYLPHENYL)AMINO] 1 (2' CYANO BIPHENYL 4 YLMETHYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 [ACETYL (3,5 DIMETHYLPHENYL)AMINO] 1 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 [ACETYL (4 ETHYLPHENYL)AMINO] 1 (2' CYANO BIPHENYL 4 YLMETHYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 [ACETYL (4 ETHYLPHENYL)AMINO] 1 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 [ACETYL (4 TERT BUTYLPHENYL)AMINO] 1 (2' CYANO BIPHENYL 4 YLMETHYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 [ACETYL (4 TERT BUTYLPHENYL)AMINO] 1 [2' (1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 [ACETYL (4 TRIFLUOROMETHYLPHENYL)AMINO] 1 (2' CYANO BIPHENYL 4 YLMETHYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 ACETYLAMINO 1 (2' CYANO BIPHENYL 4 YLMETHYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 ACETYLAMINO 1 (4 BROMO PHENYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 ACETYLAMINO 1 (4 IODO PHENYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 ACETYLAMINO 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 AMINO 1 (4 BROMO PHENYL) 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 AMINO 1 PHENYL 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 AMINO 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 3 AMINO 2 PHENYL 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 5 ACETYLAMINO 1 BUTYL 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; 5 ACETYLAMINO 1 PHENYL 1H PYRAZOLE 4 CARBOXYLIC ACID ETHYL ESTER; ACETAMIDE DERIVATIVE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; APIXABAN; BMS 561389; LOTRAFIBAN; N (1 ARYL 1H PYRAZOL 3 YL)ACETAMIDE DERIVATIVE; N ARYL N (1H PYRAZOL 3 YL)ACETAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 80052936910     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.05.056     Document Type: Article
Times cited : (15)

References (36)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.